TapewireFind a company

person · Reporting owner

SNYDERMAN RALPH

Disclosed activity across 6 companies

Tapewire entity
13158
SEC CIK
0001178031

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
ARGOS THERAPEUTICS INCARGS · Entity 167312DirectorDecember 31, 2016January 04, 2017
CareDx, Inc.CDNA · Entity 4344DirectorOctober 04, 2022October 04, 2022
Liquidia Technologies IncLQDA · Entity 145051DirectorJune 22, 2020June 23, 2020
iRhythm Holdings, Inc.IRTC · Entity 1499DirectorMay 28, 2025May 29, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ARGOS THERAPEUTICS INC

Report date December 31, 2016 · Filed January 04, 2017

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect573 Reported balance After 2016-12-31 transaction · row 1
1 source row

Row 1 · 2016-12-31 · Grant · Acquired 573 · Balance 573

F1: The reporting person has received a fully vested stock award for shares of the Company's common stock. For calendar year 2016, the Company has elected to make common stock awards in lieu of cash payments of director fees otherwise payable under the director compensation policy. The number of shares of common stock awarded represent the quotient of (A) such director fees divided by (B) the Company's closing stock price on the date awarded, rounded down to the nearest whole share of common stock.

Filing footnotes · ownership attribution and instrument terms

F1: The reporting person has received a fully vested stock award for shares of the Company's common stock. For calendar year 2016, the Company has elected to make common stock awards in lieu of cash payments of director fees otherwise payable under the director compensation policy. The number of shares of common stock awarded represent the quotient of (A) such director fees divided by (B) the Company's closing stock price on the date awarded, rounded down to the nearest whole share of common stock.

CareDx, Inc.

Report date October 04, 2022 · Filed October 04, 2022

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect58,177 Reported balance After 2022-10-04 transaction · row 1
1 source row

Row 1 · 2022-10-04 · Grant · Acquired 775 · Balance 58,177

F1: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Filing footnotes · ownership attribution and instrument terms

F1: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Liquidia Technologies Inc

Report date June 22, 2020 · Filed June 23, 2020

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.97 · Expires 2030-06-22Direct20,000 Reported balance After 2020-06-22 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2020-06-22 · Grant · Acquired 20,000 · Balance 20,000

F1: The option vests in 36 equal monthly installments, becoming fully vested on June 22, 2023.

Filing footnotes · ownership attribution and instrument terms

F1: The option vests in 36 equal monthly installments, becoming fully vested on June 22, 2023.

iRhythm Holdings, Inc.

Report date May 28, 2025 · Filed May 29, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect13,288 Reported balance After 2025-05-28 transaction · row 1
1 source row

Row 1 · 2025-05-28 · Grant · Acquired 1,358 · Balance 13,288

F1: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting.

Filing footnotes · ownership attribution and instrument terms

F1: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

PROCTER & GAMBLE Co

Report date June 10, 2010 · Filed June 11, 2010

Section 16 reporting ended · disclosed 2010-06-11. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect46,690.143 Reported balance Holding disclosure · report date 2010-06-10 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 46,690.143

F1: Total includes grant of dividend equivalents in the form of RSUs on November 16, 2009 and February 16, 2010, pursuant to Issuer's 2003 Non-Employee Directors' Stock Plan.

Filing footnotes · ownership attribution and instrument terms

F1: Total includes grant of dividend equivalents in the form of RSUs on November 16, 2009 and February 16, 2010, pursuant to Issuer's 2003 Non-Employee Directors' Stock Plan.

Press Ganey Holdings, Inc.

Report date October 21, 2016 · Filed October 25, 2016

Section 16 reporting ended · disclosed 2016-10-25. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2016-10-21 transaction · row 1
1 source row

Row 1 · 2016-10-21 · Disposition to issuer · Disposed 28,770 · Balance 0

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 28, 2025 Filed May 29, 2025 16:04 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 GrantCommon Stock 1,358 $0.00 $0.00
Disclosure

SEC source: 0001388658-25-000134 · wk-form4_1748549087.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,288

F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting.

Read SEC document
May 29, 2024 Filed Jun 3, 2024 18:47 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 GrantCommon Stock 1,841 $0.00 $0.00
Disclosure

SEC source: 0001388658-24-000117 · wk-form4_1717454855.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,930

F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting.

Read SEC document
May 24, 2023 Filed May 25, 2023 14:24 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 GrantCommon Stock 1,164 $0.00 $0.00
Disclosure

SEC source: 0001388658-23-000060 · wk-form4_1685039035.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,857

F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The RSUs fully vest on May 24, 2024.

Read SEC document
May 24, 2023 Filed Aug 16, 2023 16:14 UTC Amendment iRhythm Holdings, Inc. IRTC · Entity 1499 GrantCommon Stock 1,396 $0.00 $0.00
Disclosure

SEC source: 0001388658-23-000126 · wk-form4a_1692216880.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,089

F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The RSUs fully vest on May 24, 2024.

Read SEC document
October 04, 2022 Filed Oct 4, 2022 17:36 UTC CareDx, Inc. CDNA · Entity 4344 GrantCommon Stock 775 $0.00 $0.00
Disclosure

SEC source: 0001217234-22-000170 · wf-form4_166491940399255.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,177

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
July 01, 2022 Filed Jul 6, 2022 16:34 UTC CareDx, Inc. CDNA · Entity 4344 GrantCommon Stock 397 $0.00 $0.00
Disclosure

SEC source: 0001217234-22-000137 · wf-form4_165713965671591.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,402

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
June 16, 2022 Filed Jun 21, 2022 17:07 UTC CareDx, Inc. CDNA · Entity 4344 GrantCommon Stock · Derivative 7,606 $0.00 Strike: $20.56 $0.00
Disclosure

SEC source: 0001217234-22-000121 · wf-form4_165584562353869.xml · derivative · entry 2

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,606

Underlying: Common Stock · 7,606 shares

Expires 2032-06-16

F2 · derivative.exercise_date: 1/12th of the shares subject to the option shall vest on July 16, 2022 and the shares subject to the option shall vest monthly thereafter through June 16, 2023.

Read SEC document
June 16, 2022 Filed Jun 21, 2022 17:07 UTC CareDx, Inc. CDNA · Entity 4344 GrantCommon Stock 4,863 $0.00 $0.00
Disclosure

SEC source: 0001217234-22-000121 · wf-form4_165584562353869.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,005

F1 · shares: The reported securities are represented by restricted stock units which shall vest on June 16, 2023.

Read SEC document
May 26, 2022 Filed May 31, 2022 15:14 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 GrantCommon Stock 1,155 $0.00 $0.00
Disclosure

SEC source: 0001388658-22-000080 · wf-form4_165402445456994.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,693

F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The RSUs fully vest on May 26, 2023.

Read SEC document
June 18, 2021 Filed Jun 22, 2021 16:53 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 GrantCommon Stock 2,226 $0.00 $0.00
Disclosure

SEC source: 0001388658-21-000108 · wf-form4_162439520268959.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,538

F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The RSUs fully vest on June 18, 2022.

Read SEC document
June 16, 2021 Filed Jun 21, 2021 20:08 UTC CareDx, Inc. CDNA · Entity 4344 GrantStock Option (right to buy) · Derivative 1,812 $0.00 Strike: $88.70 $0.00
Disclosure

SEC source: 0001217234-21-000152 · wf-form4_162432047936362.xml · derivative · entry 2

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,812

Underlying: Common Stock · 1,812 shares

Expires 2031-06-16

F2 · derivative.exercise_date: 1/12th of the shares subject to the option shall vest on July 16, 2021 and the shares subject to the option shall vest monthly thereafter through June 16, 2022.

Read SEC document
June 16, 2021 Filed Jun 21, 2021 20:08 UTC CareDx, Inc. CDNA · Entity 4344 GrantCommon Stock 1,127 $0.00 $0.00
Disclosure

SEC source: 0001217234-21-000152 · wf-form4_162432047936362.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,142

F1 · shares: The reported securities are represented by restricted stock units which shall vest on June 16, 2022.

Read SEC document
June 02, 2021 Filed Jun 10, 2021 17:32 UTC CareDx, Inc. CDNA · Entity 4344 SaleCommon Stock 2,511 $81.57 $204,815.24
Disclosure

SEC source: 0001217234-21-000130 · wf-form4_162336071762244.xml · nonDerivative · entry 4

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,015

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.43 to $81.71, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.

Read SEC document
June 01, 2021 Filed Jun 10, 2021 17:32 UTC CareDx, Inc. CDNA · Entity 4344 SaleCommon Stock 2,512 $77.30 $194,173.33
Disclosure

SEC source: 0001217234-21-000130 · wf-form4_162336071762244.xml · nonDerivative · entry 3

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,526

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.28 to $77.35, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.

Read SEC document
May 28, 2021 Filed Jun 10, 2021 17:32 UTC CareDx, Inc. CDNA · Entity 4344 SaleCommon Stock 2,511 $81.08 $203,594.64
Disclosure

SEC source: 0001217234-21-000130 · wf-form4_162336071762244.xml · nonDerivative · entry 2

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,038

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.01 to $81.18, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.

Read SEC document
May 27, 2021 Filed Jun 10, 2021 17:32 UTC CareDx, Inc. CDNA · Entity 4344 SaleCommon Stock 1,966 $81.01 $159,265.66
Disclosure

SEC source: 0001217234-21-000130 · wf-form4_162336071762244.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,549

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.94 to $81.08, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.

Read SEC document
January 15, 2021 Filed Jan 19, 2021 08:58 UTC CareDx, Inc. CDNA · Entity 4344 SaleCommon Stock 12,000 $88.88 $1,066,513.20
Disclosure

SEC source: 0001217234-21-000020 · wf-form4_161106466829332.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,672

Read SEC document
January 04, 2021 Filed Jan 6, 2021 18:37 UTC CareDx, Inc. CDNA · Entity 4344 GrantCommon Stock 215 $0.00 $0.00
Disclosure

SEC source: 0001217234-21-000012 · wf-form4_160997623999508.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,672

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
October 01, 2020 Filed Oct 2, 2020 18:38 UTC CareDx, Inc. CDNA · Entity 4344 GrantCommon Stock 370 $0.00 $0.00
Disclosure

SEC source: 0001217234-20-000174 · wf-form4_160167830715413.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,457

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the Issuer's Outside Director Compensation Policy.

Read SEC document
July 01, 2020 Filed Jul 6, 2020 12:56 UTC CareDx, Inc. CDNA · Entity 4344 GrantCommon Stock 439 $0.00 $0.00
Disclosure

SEC source: 0001217234-20-000125 · wf-form4_159405458833190.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,087

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
June 22, 2020 Filed Jun 23, 2020 16:30 UTC Liquidia Technologies Inc LQDA · Entity 145051 GrantNon-Qualified Stock Option (right to buy) · Derivative 20,000 $0.00 Strike: $10.97 $0.00
Disclosure

SEC source: 0001104659-20-076077 · a4.xml · derivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2030-06-22

F1 · derivative.exercise_date: The option vests in 36 equal monthly installments, becoming fully vested on June 22, 2023.

Read SEC document
June 19, 2020 Filed Jun 23, 2020 19:46 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 GrantCommon Stock 1,056 $0.00 $0.00
Disclosure

SEC source: 0001388658-20-000132 · wf-form4_159295599792661.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,312

F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The RSUs fully vest on June 19, 2021.

Read SEC document
June 18, 2020 Filed Jun 19, 2020 21:22 UTC CareDx, Inc. CDNA · Entity 4344 GrantStock Option (right to buy) · Derivative 4,978 $31.35 Strike: $31.35 $156,060.30
Disclosure

SEC source: 0001217234-20-000104 · wf-form4_159261614816841.xml · derivative · entry 2

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,978

Underlying: Common Stock · 4,978 shares

Expires 2030-06-18

F2 · derivative.exercise_date: 1/12th of the shares subject to the option shall vest on July 18, 2020 and the shares subject to the option shall vest monthly thereafter through June 18, 2021.

Read SEC document
June 18, 2020 Filed Jun 19, 2020 21:22 UTC CareDx, Inc. CDNA · Entity 4344 GrantCommon Stock 3,190 $0.00 $0.00
Disclosure

SEC source: 0001217234-20-000104 · wf-form4_159261614816841.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,091

F1 · shares: The reported securities are represented by restricted stock units which shall vest on June 18, 2021.

Read SEC document
May 12, 2020 Filed May 13, 2020 18:56 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 SaleCommon Stock 250 $134.55 $33,637.75
Disclosure

SEC source: 0001388658-20-000086 · wf-form4_158941059830873.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,256

Read SEC document
April 01, 2020 Filed Jul 6, 2020 12:48 UTC CareDx, Inc. CDNA · Entity 4344 GrantCommon Stock 557 $0.00 $0.00
Disclosure

SEC source: 0001217234-20-000123 · wf-form4_159405407063733.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,458

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
March 04, 2020 Filed Mar 5, 2020 19:33 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 SaleCommon Stock 650 $98.85 $64,252.50
Disclosure

SEC source: 0001388658-20-000046 · wf-form4_158345476450733.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,506

Read SEC document
March 03, 2020 Filed Mar 4, 2020 20:37 UTC CareDx, Inc. CDNA · Entity 4344 Exercise / conversionEmployee Stock Option (right to buy) · Derivative 14,598 $0.00 Strike: $3.70 $0.00
Disclosure

SEC source: 0001217234-20-000043 · wf-form4_158337223087500.xml · derivative · entry 2

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,598 shares

Expires 2020-04-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: All of the shares subject to the option vested on April 8, 2010.

Read SEC document
March 03, 2020 Filed Mar 4, 2020 20:37 UTC CareDx, Inc. CDNA · Entity 4344 Exercise / conversionCommon Stock 14,598 $3.70 $53,998.00
Disclosure

SEC source: 0001217234-20-000043 · wf-form4_158337223087500.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,901

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 02, 2020 Filed Jan 3, 2020 21:07 UTC CareDx, Inc. CDNA · Entity 4344 GrantCommon Stock 653 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-000415 · doc4.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,303

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
October 01, 2019 Filed Oct 2, 2019 17:35 UTC CareDx, Inc. CDNA · Entity 4344 GrantCommon Stock 541 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-024749 · doc4.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,650

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
August 29, 2019 Filed Sep 3, 2019 16:30 UTC Liquidia Technologies Inc LQDA · Entity 145051 GrantNonqualified Stock Option (right to buy) · Derivative 7,500 $0.00 Strike: $4.52 $0.00
Disclosure

SEC source: 0001104659-19-048449 · a4.xml · derivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2029-08-29

F1 · derivative.exercise_date: The option vests in 36 equal monthly installments, becoming fully vested on May 8, 2022.

Read SEC document
July 01, 2019 Filed Jul 2, 2019 21:13 UTC CareDx, Inc. CDNA · Entity 4344 GrantCommon Stock 312 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-018992 · doc4.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,109

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
June 17, 2019 Filed Jun 19, 2019 17:58 UTC CareDx, Inc. CDNA · Entity 4344 GrantStock Option (right to buy) · Derivative 4,152 $38.26 Strike: $38.26 $158,855.52
Disclosure

SEC source: 0000899243-19-017456 · doc4.xml · derivative · entry 2

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,152

Underlying: Common Stock · 4,152 shares

Expires 2029-06-17

F2 · derivative.exercise_date: 1/12th of the shares subject to the option shall vest on July 17, 2019 and the shares subject to the option shall vest monthly thereafter through June 17, 2020.

Read SEC document
June 17, 2019 Filed Jun 19, 2019 17:58 UTC CareDx, Inc. CDNA · Entity 4344 GrantCommon Stock 2,613 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-017456 · doc4.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,797

F1 · shares: The reported securities are represented by restricted stock units which shall vest on June 17, 2020.

Read SEC document
May 22, 2019 Filed May 24, 2019 15:59 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 GrantCommon Stock 1,764 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-032666 · doc4.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,156

F1 · shares: The reported securities are represented by restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC common stock. The RSUs fully vest on May 22, 2020.

Read SEC document
April 24, 2019 Filed Apr 26, 2019 17:00 UTC Liquidia Technologies Inc LQDA · Entity 145051 Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 4,085 $0.00 Strike: $4.71 $0.00
Disclosure

SEC source: 0001104659-19-024099 · a4.xml · derivative · entry 6

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,085 shares

Expires 2025-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 24, 2019 Filed Apr 26, 2019 17:00 UTC Liquidia Technologies Inc LQDA · Entity 145051 Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 463 $0.00 Strike: $3.87 $0.00
Disclosure

SEC source: 0001104659-19-024099 · a4.xml · derivative · entry 5

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 463 shares

Expires 2023-11-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 24, 2019 Filed Apr 26, 2019 17:00 UTC Liquidia Technologies Inc LQDA · Entity 145051 Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 946 $0.00 Strike: $2.69 $0.00
Disclosure

SEC source: 0001104659-19-024099 · a4.xml · derivative · entry 4

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 946 shares

Expires 2022-12-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 24, 2019 Filed Apr 26, 2019 17:00 UTC Liquidia Technologies Inc LQDA · Entity 145051 Exercise / conversionCommon Stock 4,085 $4.71 $19,240.35
Disclosure

SEC source: 0001104659-19-024099 · a4.xml · nonDerivative · entry 3

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,356

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 24, 2019 Filed Apr 26, 2019 17:00 UTC Liquidia Technologies Inc LQDA · Entity 145051 Exercise / conversionCommon Stock 463 $3.87 $1,791.81
Disclosure

SEC source: 0001104659-19-024099 · a4.xml · nonDerivative · entry 2

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,271

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 24, 2019 Filed Apr 26, 2019 17:00 UTC Liquidia Technologies Inc LQDA · Entity 145051 Exercise / conversionCommon Stock 946 $2.69 $2,544.74
Disclosure

SEC source: 0001104659-19-024099 · a4.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,808

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 17, 2019 Filed Apr 19, 2019 13:50 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 Exercise / conversionStock Option (right to buy) · Derivative 250 $0.00 Strike: $41.04 $0.00
Disclosure

SEC source: 0001209191-19-025354 · doc4.xml · derivative · entry 2

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,839

Underlying: Common Stock · 250 shares

Expires 2027-07-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option, originally granted for 4,089 shares, of which 250 have been exercised, vested as to 1/36 of the shares on August 17, 2017 and each month thereafter.

Read SEC document
April 17, 2019 Filed Apr 19, 2019 13:50 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 Exercise / conversionCommon Stock 250 $41.04 $10,260.00
Disclosure

SEC source: 0001209191-19-025354 · doc4.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,392

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 20:27 UTC CareDx, Inc. CDNA · Entity 4344 GrantCommon Stock 343 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-009900 · doc4.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,184

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
January 02, 2019 Filed Jan 3, 2019 21:07 UTC CareDx, Inc. CDNA · Entity 4344 GrantCommon Stock 356 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-000347 · doc4.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,841

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
December 31, 2018 Filed Feb 22, 2019 21:36 UTC CareDx, Inc. CDNA · Entity 4344 GiftCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-004605 · doc5.xml · nonDerivative · entry 2

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,485

Read SEC document
December 28, 2018 Filed Feb 22, 2019 21:36 UTC CareDx, Inc. CDNA · Entity 4344 GiftCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-004605 · doc5.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,485

Read SEC document
October 01, 2018 Filed Oct 2, 2018 21:14 UTC CareDx, Inc. CDNA · Entity 4344 GrantCommon Stock 489 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-025912 · doc4.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,485

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
June 29, 2018 Filed Jul 3, 2018 17:31 UTC CareDx, Inc. CDNA · Entity 4344 GrantCommon Stock 1,197 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-019273 · doc4.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,996

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.